Similar articles for PMID: 25999415

Year	Number of Results
2004	1
2005	1
2006	1
2007	1
2008	2
2009	1
2011	5
2012	2
2013	1
2014	5
2015	11
2016	12
2017	10
2018	14
2019	15
2020	4
2023	1
2024	0

1

Establishing Amyloid PET Imaging Biomarkers: Ongoing Efforts.

Minoshima S. Minoshima S. AJNR Am J Neuroradiol. 2015 Jul;36(7):1245-6. doi: 10.3174/ajnr.A4433. Epub 2015 May 21. AJNR Am J Neuroradiol. 2015. PMID: 25999415 Free PMC article. No abstract available.

2

Distinct influence of specific versus global connectivity on the different Alzheimer's disease biomarkers.

Mutlu J, Landeau B, Gaubert M, de La Sayette V, Desgranges B, Chételat G. Mutlu J, et al. Brain. 2017 Dec 1;140(12):3317-3328. doi: 10.1093/brain/awx279. Brain. 2017. PMID: 29194503

3

Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia.

Degenhardt EK, Witte MM, Case MG, Yu P, Henley DB, Hochstetler HM, D'Souza DN, Trzepacz PT. Degenhardt EK, et al. Psychosomatics. 2016 Mar-Apr;57(2):208-16. doi: 10.1016/j.psym.2015.12.002. Epub 2015 Dec 3. Psychosomatics. 2016. PMID: 26892326 Free article.

4

Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative.

Weiner MW, Veitch DP. Weiner MW, et al. Alzheimers Dement. 2015 Jul;11(7):730-3. doi: 10.1016/j.jalz.2015.05.007. Alzheimers Dement. 2015. PMID: 26194308 Free PMC article. Review.

5

Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer's disease: first-hand experience in Thailand.

Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, Thongpraparn T, Chanachai R, Gelovani J. Thientunyakit T, et al. Nucl Med Commun. 2018 Feb;39(2):186-192. doi: 10.1097/MNM.0000000000000787. Nucl Med Commun. 2018. PMID: 29334579 No abstract available.

6

Molecular targets in the rational design of AD specific PET tracers: tau or amyloid aggregates?

Rojo LE, Gaspar PA, Maccioni RB. Rojo LE, et al. Curr Alzheimer Res. 2011 Sep;8(6):652-8. doi: 10.2174/156720511796717203. Curr Alzheimer Res. 2011. PMID: 21605040 Review.

7

Imaging. Putting PET CT to the test.

Torjesen I. Torjesen I. Health Serv J. 2014 Jun 13;124(6402):22-3. Health Serv J. 2014. PMID: 25137900 No abstract available.

8

CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.

Spallazzi M, Barocco F, Michelini G, Immovilli P, Taga A, Morelli N, Ruffini L, Caffarra P. Spallazzi M, et al. Acta Neurol Belg. 2019 Sep;119(3):445-452. doi: 10.1007/s13760-019-01112-8. Epub 2019 Mar 7. Acta Neurol Belg. 2019. PMID: 30847669

9

Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's disease.

Ofori E, DeKosky ST, Febo M, Colon-Perez L, Chakrabarty P, Duara R, Adjouadi M, Golde TE, Vaillancourt DE; Alzheimer's Disease Neuroimaging Initiative. Ofori E, et al. Neuroimage Clin. 2019;24:101985. doi: 10.1016/j.nicl.2019.101985. Epub 2019 Aug 22. Neuroimage Clin. 2019. PMID: 31470214 Free PMC article.

10

The role of PET/CT amyloid Imaging compared with Tc99m-HMPAO SPECT imaging for diagnosing Alzheimer's disease.

Suppiah S, Ching SM, Nordin AJ, Vinjamuri S. Suppiah S, et al. Med J Malaysia. 2018 Jun;73(3):141-146. Med J Malaysia. 2018. PMID: 29962497 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

78 results

Results by year